Filing Details
- Accession Number:
- 0001209191-20-047624
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-19 18:48:04
- Reporting Period:
- 2020-08-17
- Accepted Time:
- 2020-08-19 18:48:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501756 | Adverum Biotechnologies Inc. | ADVM | Biological Products, (No Disgnostic Substances) (2836) | 205258327 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1736315 | Peter Soparkar | C/O Adverum Biotechnologies, Inc. 800 Saginaw Drive Redwood City CA 94063 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-17 | 7,692 | $13.00 | 10,692 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 3,000 shares purchased under Issuer's Employee Stock Purchase Plan on May 20, 2020.
Billionaire Hedge Funds
